Education
About Us
Working with TipRanks
Follow Us
Stacy Lindborg Insider Profile
4 Followers
Stacy Lindborg, Director at Brainstorm Cell Therapeutics, holds 3.82K shares in Imunon (Ticker: IMNN), holds 48.23K shares in Brainstorm Cell Therapeutics (Ticker: BCLI).
Stacy Lindborg Brainstorm Cell Therapeutics (BCLI)Director
Brainstorm Cell Therapeutics (BCLI)
Director
Ranked #91,627 out of 103,431 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-69.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stacy Lindborg holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stacy Lindborg
Stacy Lindborg's Trading History
Brainstorm Cell Therapeutics
Jan 03, 2025
Director
Uninformative Buy
―
$32.31K
Imunon
Sep 09, 2025
President & CEO, Director
Uninformative Buy
9.59K
$19.47K
List of latest transactions for each holding click on a transaction to see Stacy Lindborg's performance on stock
You May Also Like
Stacy Lindborg insider profile FAQ
What is the percentage of profitable transactions made by Stacy Lindborg?
The percentage of profitable transactions made by Stacy Lindborg is 0%.
What is the average return per transaction made by Stacy Lindborg?
The average return per transaction made by Stacy Lindborg is -69.70%.
What stocks does Stacy Lindborg hold?
Stacy Lindborg holds: BCLI, IMNN stocks.
What was Stacy Lindborg’s latest transaction?
Stacy Lindborg latest transaction was an Uninformative Buy of $9.59K.
What was Stacy Lindborg's most profitable transaction?
Stacy Lindborg’s most profitable transaction was an Informative Buy of IMNN stock on August 16, 2024. The return on the trade was -56.90%.
What is Stacy Lindborg's role in Brainstorm Cell Therapeutics?
Stacy Lindborg's role in Brainstorm Cell Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.